ArticleLiver cancer2024

Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.